Double Controlled Release of Therapeutic RNA Modules through Injectable DNA–RNA Hybrid Hydrogel

Advances in the DNA nanotechnology have enabled the fabrication of DNA-based hydrogels with precisely controlled structures and tunable mechanical and biological properties. Compared to DNA hydrogel, preparation of RNA-based hydrogel remains challenging due to the inherent instability of naked RNA....

Full description

Saved in:
Bibliographic Details
Published in:ACS applied materials & interfaces 2020-12, Vol.12 (50), p.55554-55563
Main Authors: Han, Sangwoo, Park, Yongkuk, Kim, Hyejin, Nam, Hyangsu, Ko, Ohsung, Lee, Jong Bum
Format: Article
Language:English
Subjects:
Animals
Aptamers, Nucleotide - chemistry
Aptamers, Nucleotide - metabolism
Biological and Medical Applications of Materials and Interfaces
Drug Carriers - chemistry
Green Fluorescent Proteins - antagonists & inhibitors
Green Fluorescent Proteins - genetics
Green Fluorescent Proteins - metabolism
HeLa Cells
Humans
Hydrogels - chemistry
Mice
Mice, Nude
Optical Imaging
RNA Interference
RNA, Small Interfering - chemistry
RNA, Small Interfering - metabolism
Transplantation, Heterologous
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Advances in the DNA nanotechnology have enabled the fabrication of DNA-based hydrogels with precisely controlled structures and tunable mechanical and biological properties. Compared to DNA hydrogel, preparation of RNA-based hydrogel remains challenging due to the inherent instability of naked RNA. To overcome these limitations, we fabricated a DNA–RNA hybrid hydrogel via stepwise dual enzymatic polymerization. Multimeric short hairpin RNAs (shRNAs) were hybridized with functional DNA aptamers for targeting and mechanical properties of the hydrogel. The obtained DNA–RNA hybrid hydrogel was ultrasoft, robust, and injectable hence reconfigurable into any confined structures. As a model system, the hydrogel was able to mimic microtubule structures under physiological conditions and designed to release the functional small interfering RNA (siRNA)–aptamer complex (SAC) sequentially. In addition, we encoded restriction enzyme-responsive sites in DNA–RNA hybrid hydrogel to boost the release of SAC. This novel strategy provides an excellent platform for systematic RNA delivery through double-controlled release, SAC release from hydrogel, and subsequent release of siRNA from the SAC, which has promising potential in RNA therapy.
ISSN:1944-8244
1944-8252
DOI:10.1021/acsami.0c12506